More PRNewswire

View Older Stories View Newer Stories

Jan 3, 2024 07:05AM South Rampart Pharma to Present at Biotech Showcase 2024
Jan 3, 2024 07:01AM Global Times: China practices wise foreign policy in managing relations
Jan 3, 2024 07:01AM Veteran Experts Raise Alarm Bells as Homelessness Rates Increase for the First Time in 12 Years
Jan 3, 2024 07:01AM SPICE UP YOUR WINTER AT THE COFFEE BEAN & TEA LEAF AND ENJOY THE RETURN OF WHITE AND DARK CHOCOLATE
Jan 3, 2024 07:00AM Nano Labs Announced Updates to Holders of ADRs Regarding Amendment to the Deposit Agreement and Termination of ADR Facility
Jan 3, 2024 07:00AM Nova to Present at the 26th Annual Needham Growth Conference
Jan 3, 2024 07:00AM Brii Biosciences Appoints Dr. Brian Alvin Johns as Chief Scientific Officer
Jan 3, 2024 07:00AM ZINFI Releases Its Latest Complimentary Best Practices Guidebook: "The Ultimate Guide to Channel Partner Management"
Jan 3, 2024 07:00AM AKTIS ONCOLOGY TO PRESENT AT THE 42ND ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
Jan 3, 2024 07:00AM Lifestory Research Unveils 2024 America's Most Trusted® Cleaning Products and Appliances: A Comprehensive Overview of Consumer Trust in Home Care
Jan 3, 2024 07:00AM Chemomab Announces Completion of Patient Enrollment in CM-101 Phase 2 Primary Sclerosing Cholangitis Trial and Moves Up Expected Topline Readout to Midyear 2024
Jan 3, 2024 07:00AM Consumer Trust Amplified: Lifestory Research Unveils 2024 America's Most Trusted® Home Design Brands
Jan 3, 2024 07:00AM A Decade of Trust: Lifestory Research Celebrates 10 Years of America's Most Trusted® HVAC Study
Jan 3, 2024 07:00AM Lifestory Research Recognizes Brands Earning Customer Trust for the 5th Consecutive Year in America's Most Trusted® Studies
Jan 3, 2024 07:00AM Alkermes Announces Topline Results From Long-Term, Open-Label Safety and Durability of Treatment Effect Study of LYBALVI® (olanzapine and samidorphan)
Jan 3, 2024 07:00AM Lifestory Research Releases 2024 America's Most Trusted Home Builder Study Findings
Jan 3, 2024 07:00AM Ceva Extends its Connect IP Portfolio with Wi-Fi 7 Platform for High-End Consumer and Industrial IoT
Jan 3, 2024 07:00AM Ginkgo Bioworks Announces Participation in the 42nd Annual J.P. Morgan Healthcare Conference
Jan 3, 2024 07:00AM Blue Kangaroo Packoutz Celebrates 100th Territory Opening
Jan 3, 2024 07:00AM Hughes Named a Strong Performer in 2023 Gartner® Peer Insights™ Voice of the Customer for Managed Network Services
Jan 3, 2024 07:00AM Main Street Announces Follow-On Investment
Jan 3, 2024 07:00AM Seeing Machines to showcase cutting edge interior sensing technology at CES 2024
Jan 3, 2024 07:00AM Tint World® continues rapid growth in Texas with new location in Universal City
Jan 3, 2024 07:00AM Karyopharm to Present at 42nd Annual J.P. Morgan Healthcare Conference
Jan 3, 2024 07:00AM RADCOM to Present at the 26th Annual Needham Growth Conference on Thursday, January 18
Jan 3, 2024 07:00AM Leap Therapeutics to Participate at the 42nd Annual J.P. Morgan Healthcare Conference
Jan 3, 2024 07:00AM VITA INCLINATA TECHNOLOGIES CLOSES $44M ROUND
Jan 3, 2024 07:00AM With Recent Recognition for Its Data Privacy Benefits, ShardSecure® Joins Google Cloud Partner Advantage
Jan 3, 2024 07:00AM Ceragon Networks to Participate in the Needham Growth Conference
Jan 3, 2024 07:00AM Remix Therapeutics Closes $60 Million Financing to Advance REM-422, Pipeline of Small Molecule Therapies Designed to Reprogram RNA Processing to Treat Disease
Jan 3, 2024 07:00AM Remix Therapeutics Enters Collaboration with Roche for the Discovery and Development of Small Molecule Therapeutics Modulating RNA Processing
Jan 3, 2024 07:00AM EX.CO Debuts Vertical Video Player for Publishers' Websites, Bridging the Gap Between Social Media Platforms and the Open Web
Jan 3, 2024 07:00AM Powering Trust: Lifestory Research Unveils the Top Brands in 2024 America's Most Trusted® Energy-Efficient Product Studies
Jan 3, 2024 07:00AM Retail Media Innovator Melanie Zimmermann joins Criteo to Lead its Global Retail Media Practice
Jan 3, 2024 07:00AM ZILBRYSQ® (zilucoplan) Is Now Commercially Available in the U.S. for the Treatment of Generalized Myasthenia Gravis (gMG) in Adult Patients Who Are Anti-Acetylcholine Receptor (AChR) Antibody Positiv
Jan 3, 2024 07:00AM Lifestory Research Unveils 2024 America's Most Trusted® Consumer Technology Brands: Consumer Trust Amplified
Jan 3, 2024 07:00AM Capital Square Acquires Tennessee Build-for-Rent Townhome Community for DST Offering
Jan 3, 2024 07:00AM Key Foundry Changes Its Name to "SK keyfoundry"
Jan 3, 2024 06:58AM Talos Energy Starts Production at Lime Rock and Venice Gulf of Mexico Discoveries
Jan 3, 2024 06:46AM Wishew: The Social Network that Grants Wishes - A New Frontier in the Era of the Social Media
Jan 3, 2024 06:46AM Chengdu Hi-tech Zone Jiaozi Avenue Metaverse District Opens on the 1st Day of the New Year
Jan 3, 2024 06:43AM WITH THE NEW YEAR, AMERICANS LOOK TO MODERATE ALCOHOL INTAKE
Jan 3, 2024 06:30AM ACL Digital certified as a Great Place To Work® Second Year in a Row
Jan 3, 2024 06:30AM Peavey Electronics Debuts New Website Design by Cardwell Beach
Jan 3, 2024 06:26AM Ribo partners with Boehringer Ingelheim to develop new treatments for people with liver diseases
Jan 3, 2024 06:09AM The PenFed Foundation partners with Canine Companions to help more veterans get life-changing service dogs
Jan 3, 2024 06:05AM U-Haul Migration Trends: Florida had 7 of Top 25 U.S. Growth Cities in 2023
Jan 3, 2024 06:00AM Emeren Group Releases 2022 Environmental, Social and Governance Report
Jan 3, 2024 06:00AM Braille Institute Celebrates 5th Annual "Assistive Technology Month" In January
Jan 3, 2024 06:00AM BrandEd Announces CEO Transition
View Newer Stories View Older Stories